Safety of a Candidate Bioconjugate Vaccine Against Shigella Flexneri 2a

Condition:   ShigellosisInterventions:   Biological: Flexyn2a;   Biological: Placebo;   Biological: Flexyn2a plus adjuvantSponsors:   GlycoVaxyn AG;   Wellcome Trust;   Naval Medical Research CenterActive, not recruiting - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials